John Bencich insider trades

Open-market stock purchases and sales by John Bencich, CHIEF FINANCIAL OFFICER at AEON Biopharma, Inc, from SEC Form 4 filings since Jan 29, 2010.

Track record: 67% of 3 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Apr 2, 2026AEON AEON Biopharma, IncBought (not open market)—

Companies traded

  • AEON AEON Biopharma, Inc: other filings, last Apr 2, 2026
  • ACHV Achieve Life Sciences, Inc: 5 buys, last Aug 16, 2024
  • OGXI Oncogenex Pharmaceuticals, Inc: 3 sales, last Jan 10, 2017
  • TRBN Trubion Pharmaceuticals, Inc: other filings, last Oct 28, 2010

Get free alerts when John Bencich files a new trade →